Recent Finacing
Recent Raise
Synerkine Pharma develops cytokine fusion proteins (IL‑4/IL‑10) to modulate immune signaling for inflammatory, neuropathic, and osteoarthritic pain, advancing lead SK‑01 through preclinical studies and manufacturing scale‑up from Utrecht, Netherlands.
